report organ revenu growth street
estim non-gaap ep street estim
manag call sever transient item remedi stretch
consequ take forward revenu estim manag
rais ep lower organ growth fx trim addit macro
headwind increment lower confid manag abil hit forward
expect thu believ stock could trade sideway near term accordingli
downgrad share neutral price target
result revenu grew organ street
organ estim discoveri analyt system da grew
organ report street estim diagnost
grew organ report well street estim
adjust gross margin improv bp street
estim adjust oper margin expand bp street
estim non-gaap ep street expect
busi updat quarter initi anoth reorgan
design streamlin sever function reduc overal oper expens
addit sever item neg impact result includ appli
genom busi -msd genom lab consolid
exist facil pittsburgh lab move fulli back former capac
prolong revenu drag posit key busi
euroimmun cannabi initi tulip informat life scienc imag
perform well partial offset aforement appli genomics/genom lab
appli segment flat yoy perkin also announc acquisit
meizheng chinese-bas food test compani deal term includ mid
close deal price revenu growth profil time
deal curiou given challeng chines market although competitor agil
construct segment recent meet compani
street adjust ep
guidanc street revenu guidanc
street ep street macro concern combin
certain sudden segment chang leav us increment less confid forward
consensu expect accordingli downgrad neutral given lower
growth expect believ multipl appropri
yield new price target
competit emerg disrupt technolog new product execut fx
develop manufactur sell product environment market
price close octob
forma ep
debt total capit
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
million
good sold
good sold acquisit relat
provis incom tax
good sold
research develop
compani report piper jaffray co up-to-d compani disclosur inform pleas visit http //www piperjaffray com/researchdisclosur
